PRISMAP: A European network for medical radioisotope production and research

October 1, 2021, 12:00PMNuclear News
A conceptual image of collaboration across Europe. (Image: PRISMAP/SCIPROM)

Only a few of the more than 3,000 radioisotopes that scientists have synthesized in the laboratory are regularly used in diagnostic or therapeutic medicine. One significant barrier to the development of new medical radioisotopes is the difficulty of gaining access to radionuclides during the early stages of development and research. PRISMAP is a new medical radionuclide program designed to streamline that access for medical research in the European Union and the United Kingdom.

To continue reading, log in or create a free account!

Related Articles

How can we shape the global nuclear future?

March 20, 2025, 9:30AMNuclear NewsFiona Rayment

Shaping the global nuclear future requires an understanding of nuclear’s role in addressing national and energy security endeavors together with foresight into the energy sector’s future...

Robotics milestone reached at Sellafield

March 19, 2025, 12:00PMNuclear News

Sellafield Ltd. and AtkinsRéalis have successfully operated a robotic dog from a remote location in what might be the first time such an operation has happened at a nuclear licensed site,...